
Carl Bell
Ask VT AI
View News Summary
- Carlsberg's Q1 sales miss expectations, but the company maintains its full-year guidance amid global economic risks.
- Pfizer reports 8% revenue decline, reaffirms 2025 guidance, and pursues aggressive cost-cutting measures to offset challenges.
- Retrial of Karen Read focuses on cellphone data, disputed Google search, and expert testimony as key evidence amid allegations of a cover-up.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Carlsberg's Q1 sales miss expectations, but the company maintains its full-year guidance amid global economic risks.
- Pfizer reports 8% revenue decline, reaffirms 2025 guidance, and pursues aggressive cost-cutting measures to offset challenges.
- Retrial of Karen Read focuses on cellphone data, disputed Google search, and expert testimony as key evidence amid allegations of a cover-up.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Carl Bell
News from Carl Bell